At a Glance
Dosage
Only in 1cP-LSD
oral
| Level | Dose |
|---|---|
| Threshold | 15 µg |
| Light | 25–75 µg |
| Common | 75–150 µg |
| Strong | 150–300 µg |
| Heavy | 300 µg |
Only in 25C-NBOMe
sublingual
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 100–300 µg |
| Common | 300–700 µg |
| Strong |
Duration
Only in 1cP-LSD
oral
Total: 8 hrs – 12 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up45 min – 2 hrs
Peak3 hrs – 5 hrs
Offset3 hrs – 5 hrs
Effects
Safety
Interaction: 1cP-LSD + 25C-NBOMe
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-LSD — Dangerous Interactions
No dangerous interactions recorded.
25C-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-LSD and 25C-NBOMe?
1cP-LSD is classified as a Psychedelic (Lysergamides) while 25C-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 48 effects in common, with 29 effects unique to 1cP-LSD and 23 unique to 25C-NBOMe.
Is it safe to combine 1cP-LSD and 25C-NBOMe?
There is no direct interaction data available for combining 1cP-LSD and 25C-NBOMe. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-LSD or 25C-NBOMe?
1cP-LSD and 25C-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.